Logo image of ZONE

CLEANCORE SOLUTIONS INC-CL B (ZONE) Stock Fundamental Analysis

NYSEARCA:ZONE - NYSE Arca - US1844921064 - Common Stock - Currency: USD

1.08  -0.01 (-1.1%)

After market: 1.05 -0.03 (-2.78%)

Fundamental Rating

1

Taking everything into account, ZONE scores 1 out of 10 in our fundamental rating. ZONE was compared to 128 industry peers in the Machinery industry. ZONE has a bad profitability rating. Also its financial health evaluation is rather negative. ZONE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ZONE has reported negative net income.
ZONE had a negative operating cash flow in the past year.
ZONE Yearly Net Income VS EBIT VS OCF VS FCFZONE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

With a Return On Assets value of -30.50%, ZONE is not doing good in the industry: 87.20% of the companies in the same industry are doing better.
The Return On Equity of ZONE (-61.07%) is worse than 83.20% of its industry peers.
Industry RankSector Rank
ROA -30.5%
ROE -61.07%
ROIC N/A
ROA(3y)-49.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZONE Yearly ROA, ROE, ROICZONE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

ZONE has a better Gross Margin (49.58%) than 92.80% of its industry peers.
In the last couple of years the Gross Margin of ZONE has grown nicely.
ZONE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.73%
GM growth 5YN/A
ZONE Yearly Profit, Operating, Gross MarginsZONE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

3

2. Health

2.1 Basic Checks

ZONE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZONE has been increased compared to 1 year ago.
Compared to 1 year ago, ZONE has an improved debt to assets ratio.
ZONE Yearly Shares OutstandingZONE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
ZONE Yearly Total Debt VS Total AssetsZONE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

Based on the Altman-Z score of -0.25, we must say that ZONE is in the distress zone and has some risk of bankruptcy.
ZONE has a worse Altman-Z score (-0.25) than 74.40% of its industry peers.
ZONE has a Debt/Equity ratio of 0.70. This is a neutral value indicating ZONE is somewhat dependend on debt financing.
The Debt to Equity ratio of ZONE (0.70) is worse than 72.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z -0.25
ROIC/WACCN/A
WACC12.07%
ZONE Yearly LT Debt VS Equity VS FCFZONE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 2.13 indicates that ZONE has no problem at all paying its short term obligations.
ZONE's Current ratio of 2.13 is in line compared to the rest of the industry. ZONE outperforms 52.00% of its industry peers.
A Quick Ratio of 1.69 indicates that ZONE should not have too much problems paying its short term obligations.
ZONE's Quick ratio of 1.69 is fine compared to the rest of the industry. ZONE outperforms 69.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.69
ZONE Yearly Current Assets VS Current LiabilitesZONE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

0

3. Growth

3.1 Past

ZONE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.12%, which is quite impressive.
The Revenue for ZONE has decreased by -34.26% in the past year. This is quite bad
The Revenue has been decreasing by -1.36% on average over the past years.
EPS 1Y (TTM)27.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.23%
Revenue 1Y (TTM)-34.26%
Revenue growth 3Y-1.36%
Revenue growth 5YN/A
Sales Q2Q%51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZONE Yearly Revenue VS EstimatesZONE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ZONE Yearly EPS VS EstimatesZONE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZONE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZONE Price Earnings VS Forward Price EarningsZONE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZONE Per share dataZONE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZONE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEANCORE SOLUTIONS INC-CL B

NYSEARCA:ZONE (2/21/2025, 8:04:00 PM)

After market: 1.05 -0.03 (-2.78%)

1.08

-0.01 (-1.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.47%
Inst Owner Change1152.43%
Ins Owners61.59%
Ins Owner Change0.63%
Market Cap9.19M
AnalystsN/A
Price TargetN/A
Short Float %3.47%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.73
P/FCF N/A
P/OCF N/A
P/B 2.46
P/tB 790.27
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.19
BVpS0.44
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.5%
ROE -61.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.58%
FCFM N/A
ROA(3y)-49.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.73%
GM growth 5YN/A
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.73%
Cap/Sales 0.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 1.69
Altman-Z -0.25
F-Score4
WACC12.07%
ROIC/WACCN/A
Cap/Depr(3y)62.65%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.26%
Revenue growth 3Y-1.36%
Revenue growth 5YN/A
Sales Q2Q%51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y61.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-338.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-337.11%
OCF growth 3YN/A
OCF growth 5YN/A